Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Perspective Therapeutics (CATX) Times Interest Earned (2016 - 2025)

Perspective Therapeutics' Times Interest Earned history spans 9 years, with the latest figure at $616.22 for Q4 2024.

  • For Q4 2024, Times Interest Earned rose 226.66% year-over-year to $616.22; the TTM value through Sep 2025 reached $1522.3, up 483.37%, while the annual FY2024 figure was -$1893.5, 279.24% down from the prior year.
  • Times Interest Earned for Q4 2024 was $616.22 at Perspective Therapeutics, up from -$270.06 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $616.22 in Q4 2024 and bottomed at -$696.43 in Q3 2023.